Background An ageing population leads to increasing prevalence of age-related chronic conditions that present challenges to the health-care services. Despite this, in countries including Ireland, little is known about the health-care impact of conditions such as osteoarthritis or rheumatoid arthritis amongst older adults.
Background
Musculoskeletal disorders are a leading cause of long-term disability. 1, 2 One of the most commonly occurring types of musculoskeletal disorder is osteoarthritis where in the USA prevalence has been estimated at 13.9% among those aged 25 and older increasing to 33.6% among those aged 65 and older.
3 While the prevalence of rheumatoid arthritis, another musculoskeletal condition is lower-the majority of prevalence studies suggest a prevalence of 0.05-1.1% worldwide 4 -it too effects a large number of people and is associated with ageing. 5 As populations in many developed countries age and so the number of persons affected by such conditions is predicted to increase, 6 a fact reflected in the international interest that the conditions have attracted-the United Nations, the World Health Organization and a number of individual countries, for example, proclaiming 2000-2010 to be the 'Bone and Joint Decade'. 2 The impact on prevalence of population ageing has been noted within the international literature and previous studies have attempted to address this when producing estimates of the burden associated with the conditions. While a number of studies have explored the direct and indirect costs of both osteoarthritis and rheumatoid arthritis separately as well as in terms of their combined impact on the health service and society more generally, differences in the methods used, in the antiquity of the studies, in the structure of and entitlements offered by health-care systems and in the populations studied, however, make it difficult to generalize results from one population to another. In respect of osteoarthritis, for example, a study by March and Bachmeier 7 reported that the total cost of osteoarthritis was between 1 and 2.5% of Gross National Product in the USA, Canada, UK, France and Australia but these estimates may be somewhat antiquated. This is an important point given the findings of Le Pen et al. 8 who highlighted the speed with which cost estimates change [estimates in France rising (by 156%) over the course of 10 years]. More recent work by Chen et al.
2 note the paucity of peer-reviewed literature when exploring the direct or indirect costs of osteoarthritis in countries such as the UK. While evidence in respect of rheumatoid arthritis appears somewhat more robust (a large number of recent studies having been conducted and several systematic reviews having explored these costs (see Furneri et al. 9 ), again a paucity of data is evident in respect of several countries. Lundkvist et al. 10 report the direct medical costs associated with rheumatoid arthritis at E14 billion per year in Europe but for a number of countries such as Ireland no data were directly available, leading to imputed estimates. As little is known about the burden of these conditions in an Irish context it is unsurprising that little is also known about the distribution of costs across health-care services in Ireland. This is particularly significant given planned changes to access arrangements for GP care in Ireland and the impact these may in turn have upon the burden of illness.
Within a context in which population ageing is set to place increasing pressure on the health-care system generally and in which access arrangements in Ireland are set to change it is important that policy-makers have a better understanding of the impact on health care of these conditions. The objective of this paper is to estimate the burden of both osteoarthritis and rheumatoid arthritis in an older adult population in the Republic of Ireland and describe how that burden is distributed across different health service providers. We also estimate the potential additional cost associated with these arthritic conditions assuming GP care is provided free at point of delivery to everyone.
The remainder of this paper is developed as follows. Our methodological approach is outlined next followed by a brief description of the data. We then present the results in terms of the additional health-care use across a range of services attributable to these conditions as well as the cost associated with this. We complete the paper with a discussion of the findings and potential policy implications arising from this research.
Methods
We model health-care use with respect to GP and hospital services using count data that identify how frequently specific services are used over a 12 month period. In this case we assume that utilization of a particular health-care service is determined by a series of explanatory variables as follows:
where x i is a vector explanatory variables that include the presence of an arthritic condition and the socio-demographic characteristics of the respondent. In Ireland a mixed publicprivate health-care system operates both in terms of finance and delivery. Those without a medical card must pay a contribution for visiting the GP and for hospital inpatient stays ( E60 per visit/night) as well as the full costs of prescription medications. 11 Approximately 30% of the general population in Ireland have a medical card, just under half have private health insurance and some have medical cards and private insurance (thought to afford speedier access to follow-on care where necessary). 12 Until the end of 2008, any individual aged 70 years or older were entitled to a medical card, whereas after this period entitlement for these individuals has been means tested. The varying entitlements evident in the funding system have been shown to impact upon service use in a number of studies and in consequence we control for these in our model. 13 -15 We also control for a range of other potential health conditions to capture their contribution to health-care usage among the older adult population in Ireland. Arthritis can be associated with other co-morbid conditions, such as pain, therefore we control for these separately along with other health conditions. As a final control variable we include self-assessed health status. Data are taken from TILDA, a nationally representative survey of over 8000 individuals aged 50 and over (and their spouses and partners of any age) collected during 2009. Extensive discussion of the survey design is provided by Kenny et al. 16 Four aspects of health-care services are modelled: visits to the GP; visit to the hospital as an outpatient; visits to the accident and emergency (A&E) department and the number of inpatient nights. (The choice of services modelled was based on data availability in TILDA). The use of services is modelled with a negative binomial specification which allows for overdispersion of the data by assuming that the individual error term derives from the gamma distribution. This model has been used extensively in studies of health-care utilization. 17 TILDA focuses on individuals aged 50 and over. To provide assurance as to the representativeness of our estimates we explored the prevalence of arthritis for the under 50 s using Slán 2007 data (which is representative of the adult population aged 18 years and over) and we found that only 1% of those who were aged under 50 reported having either type of arthritis. It therefore seems reasonable to assert that the results are representative of the arthritic individuals in Ireland.
Estimating direct health-care costs of arthritis
We present the incremental health-care cost estimates associated with both types of arthritis (that is, how much more a person with these conditions costs, relative to those without the conditions, everything else being the same). We present costs for significant marginal effects (ME) only. To estimate the overall costs we use the following formula: ME Â Average cost of health-care service use Â proportion in over 50-year-old population that has that condition The ME is the average marginal effect from the respective count data models. In the case of GP visits the average cost of a visit is E50-this is the average cost that respondents in Tilda stated they paid for a visit to the doctor (among those respondents who had to pay). This figure has also been used in previous studies in Ireland. 18, 19 In the case of outpatient costs we use costs presented in Perry et al., 20 which uses an average cost of an outpatient visit of E139 per visit. Prior to reporting the population level costs, we estimate costs at the individual level (simply estimated as the ME Â average cost of health-care service).
Results
Before proceeding to our models we provide an overview of the variables that are included in the econometric analysis as well as their percentage breakdown in Table 1 . We applied sampling weights to correct for potential over or under representativeness of any subgroups in the analysis. These weights were given as part of the Tilda data set.
As shown in Table 1 , approximately half of the respondents in the sample have access to either a medical card and/or private health insurance. While not reported in Table 1 , we note that 88% of the sample had visited a doctor during the previous 12-month period; 40% had an outpatient visit; 16% had visited the A and E department and 13% had an overnight stay at a hospital.
Approximately 27% of the sample reported that they had been told by a doctor that they have an arthritic condition. Approximately 12% have osteoarthritis and 9% have rheumatoid arthritis. Approximately 19% of respondents aged between 70 and 79 years report having osteoarthritis compared with 8 per cent of those aged between 50 -59 years. We also note that the prevalence of both types of arthritis is higher among medical card holders than non-medical card holders. For instance, 15% of medical card holders report that they have osteoarthritis compared with 10% of non-medical card holders. The difference is even larger in the case of rheumatoid arthritis where 12% of medical card holders report having rheumatoid arthritis compared with 5% of non-medical card holders, an issue we return to below.
The results of the count models in respect of health-care use are presented in Table 2 .
The results highlight that even when controlling for other health conditions and pain severity, both osteoarthritis and rheumatoid arthritis significantly increase the frequency of visiting the GP and the outpatients' clinic. The presence of osteoarthritis is predicted to result in 0.31 more visits to the doctor, while rheumatoid arthritis is predicted to result in 0.53 more visits to the doctor compared with someone who does not have either of these conditions. In the case of A and E and inpatient episodes we do not find a statistically significant relationship in respect of these conditions.
In the interest of brevity we do not provide a detailed discussion of the other variables in the model but we do highlight several findings. First, in the case of gender and marital status we note that these are significant predictors of the number of inpatient nights. For instance, men, individuals who are single, separated, divorced or widowed stay in the hospital longer than women or married/cohabiting individuals, respectively. In the latter case this likely reflects the fact that married or cohabiting individuals have a greater likelihood of being looked after by their partner at home compared with single individuals. Workers have a significantly lower frequency of use of GP and outpatient services. In the case of age and education we note that these are only significant for some services and only some of the categories associated with these variables are significant [notably for individuals aged over 80 (compared with those aged under 55) and third level education (compared with primary education level only)]. Medical card status plays a role in predicting utilization for all the services except for outpatient appointments. For GP services in particular, the effect of medical card status is quite large (suggesting an average increase in 1.62 visits per annum for medical card holders). Private health insurance is only significant in the case of inpatient nights. Finally, we note that self-reported health status and a number of the health conditions are significant across the models.
Direct health-care costs of arthritis
In Table 3 we present the incremental health-care cost estimates associated with both types of arthritis. We find that a patient with osteoarthritis cost E15 more in GP visits compared with a patient without osteoarthritis other variables controlled for [confidence interval (CI): E3-E27]. In the case of rheumatoid arthritis we find that these patients cost on average E26 more per individual compared with a person who does not have rheumatoid arthritis other variables controlled for (CI: E12 -E40). As shown in Table 3 , when we extrapolate the costs up to the population level the overall difference in GP costs between osteoarthritis and rheumatoid arthritis is relatively small. The reason for this is that while the individual costs associated with rheumatoid arthritis are higher, there is a higher prevalence of osteoarthritis in the population. Furthermore, we do not find that in the case of outpatient visits the individual level costs are much different between osteoarthritis (E30, CI: E9 -51) and rheumatoid arthritis (E34, CI: E7-E61).
We also estimated differences in costs between arthritic patients who possess a medical card compared with those who do not possess a medical card. We find that an osteoarthritis patient who has a medical card costs E18 more in GP visits compared with E11 more for a non-medical card holder with osteoarthritis relative to those who do not have the condition. For rheumatoid arthritis we find that a patient with a medical card cost E30 more compared with E19.50 more for a non-medical card holder who has rheumatoid arthritis relative to those who do not have this condition. We Percentages are rounded. For any of the health conditions, these were conditions that the respondent was told by a doctor that they have/had. ***Significance at the 1% level, **at the 5% level, *at the 10% level. use these figures to project costs for these conditions where GP care to be provided free at the point of delivery to all in Ireland. In the case of osteoarthritis the additional cost to the state per annum would be E400 000. The equivalent additional costs associated with rheumatoid arthritis are estimated at E450 000 per annum.
HEALTH-CARE USAGE ASSOCIATED WITH OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS

Discussion
Main findings of this study
The incremental impact on health-care utilization associated with osteoarthritis and rheumatoid arthritis in Ireland are significant and fall predominantly on GP and outpatient services. While the additional costs in terms of outpatient services are broadly the same across both conditions, in respect of GP services rheumatoid arthritis patients are seen to cost substantially more than osteoarthritis patients at the individual level. Extrapolating up to the population level suggests a similar overall burden for both arthritic conditions, reflecting the higher prevalence of osteoarthritis in the population. Variation in service utilization and by inference cost across different groups is consistent with intuition and instructive. For example, with respect to the role of marital status it is notable that those who are single make greater use of hospital inpatient stays than those who are married perhaps suggesting a greater role for informal carers among married couples.
What is already known on this topic
That those with medical cards make greater use of services than those without is consistent with the findings of others and highlights the deterrent effect of out of pocket payments for access to services. Furthermore, there is a role for private health insurance in ensuring access to hospital overnight stays for older patients. These results point to differences in service use related to non-need aspects of the respondent including medical card status and possession of insurance, which was confirmed by other studies conducted in Ireland. 13 -15 That these conditions present an additional economic burden for the health-care system is consistent with international findings 2, 21 and should be of interest to policy-makers planning the future provision of services. 22 
What this study adds
The differential impact across health-care settings is notable and provides potentially useful information for policy-makers in terms of planning future service provision. The incremental impact of these conditions is, for example, most notable in GP and outpatient care rather than in A&E or inpatients. The increased emphasis on primary care provision in Ireland should (if successful) help policy-makers better accommodate the pressure from this source that will accompany population ageing (however this will be complicated both by issues regarding the supply of GPs and the proposed increase in access to GP services associated with universal coverage). While the additional cost associated with arthritic conditions, estimated here may seem modest-the incremental cost per annum associated with GP services, for example, being E850 000, it should be noted that it excludes prescribed and other medicines which are a significant component of cost in the treatment of both conditions. Moreover, within a context in which ageing will increase pressure on services for a range of chronic conditions, in which there are policy moves to increase access to GP and other ambulatory services it is important that policy-makers fully appreciate the combined impact such changes might have.
Limitations of this study
This study is likely to underestimate the true direct burden from these arthritic conditions as medications and other potential services accessed by arthritis patients such as physiotherapy services were not included in the analysis.
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